← Back to Search

Other

Ovarian Tissue Cryopreservation for Pediatric Cancer Patients

N/A
Waitlist Available
Led By Zaraq Khan, M.B.B.S.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female, age birth-17 years
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-20 years
Awards & highlights

Study Summary

This trial is designed to offer ovarian tissue cryopreservation to female pediatric patients with fertility threatening medical diagnoses.

Who is the study for?
This trial is for girls from birth to 17 years old with conditions that threaten fertility, such as cancer or Turner's syndrome. They must be facing treatments like surgery, chemo, or radiation that could harm their ovaries. Girls who can't fully consent or have severe ovarian damage aren't eligible.Check my eligibility
What is being tested?
The study offers ovarian tissue cryopreservation—an experimental procedure to save and freeze ovarian tissue—to young female patients at risk of losing reproductive potential due to medical treatments.See study design
What are the potential side effects?
Since this is a preservation technique rather than a drug treatment, the main risks involve surgical complications and the effects of anesthesia required for the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a girl 17 years old or younger.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10-20 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10-20 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of pregnancy and live births after transplantation of cryopreserved ovarian tissue

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ovarian tissue cryopreservationExperimental Treatment1 Intervention
Children faced with a fertility threatening diagnosis or treatment plan will be offered ovarian tissue cryopreservation, particularly if pre menarchal and without other options to preserve fertility. Although considered experimental, there are over 120 live births worldwide using this technique

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,766,983 Total Patients Enrolled
Zaraq Khan, M.B.B.S.Principal Investigator - Mayo Clinic
Mayo Clinic Hospital-Rochester Saint Marys Campus, Mayo Clinic Rochester

Media Library

Ovarian tissue cryopreservation (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02646384 — N/A
Cancer Research Study Groups: Ovarian tissue cryopreservation
Cancer Clinical Trial 2023: Ovarian tissue cryopreservation Highlights & Side Effects. Trial Name: NCT02646384 — N/A
Ovarian tissue cryopreservation (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02646384 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being treated in the current experiment?

"Affirmative. The information listed on clinicaltrials.gov suggests that this trial is actively enrolling patients, and was initially posted in March of 2017 with a recent update occurring February 1st 2022. Presently the study seeks to recruit 100 subjects from one site."

Answered by AI

Are there still opportunities for people to participate in this experiment?

"Affirmative. According to the clinicaltrials.gov website, this research project is still open for enrollment. It was initially posted on March 16th 2017 and has been recently updated on February 1st 2022. The goal of the study is to recruit 100 patients from one location."

Answered by AI
~18 spots leftby Dec 2025